Relevium Technologies (CVE:RLV) Sets New 52-Week Low at $0.07

Relevium Technologies Inc (CVE:RLV)’s stock price reached a new 52-week low during trading on Friday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 327000 shares. The stock had previously closed at C$0.07.

The company has a 50 day simple moving average of C$0.08. The company has a quick ratio of 0.57, a current ratio of 1.26 and a debt-to-equity ratio of 64.68. The company has a market cap of $9.16 million and a price-to-earnings ratio of -1.86.

Relevium Technologies Company Profile (CVE:RLV)

Relevium Technologies Inc engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and nutri cosmeceuticals primarily through its Bioganix brand portfolio online, as well as dietary supplements under the LeefyLyfe brand name through its wholesale, retail, and online distribution channels.

Featured Article: Leveraged Buyout (LBO)

Receive News & Ratings for Relevium Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relevium Technologies and related companies with MarketBeat.com's FREE daily email newsletter.